Cliical Trials: Portfolio & Program Management

Integrating Portfolio & Program Management Across Vendors, Functions and Regions Effective integration of portfolio and program management is crucial in the landscape of clinical trials, particularly when addressing patient enrollment in clinical trials. This step-by-step tutorial guide will elaborate on strategies for integrating management across various vendors, functions, and regions, emphasizing the considerations pertinent to…

Read More “Integrating Portfolio & Program Management Across Vendors, Functions and Regions” »

Integrating Portfolio & Program Management Across Vendors, Functions and Regions Integrating Portfolio & Program Management Across Vendors, Functions and Regions In the current landscape of clinical research, effective integration of portfolio and program management is vital for ensuring successful clinical trials. Professionals involved in clinical operations, regulatory affairs, and medical affairs must have a thorough…

Read More “Integrating Portfolio & Program Management Across Vendors, Functions and Regions” »

Case Studies: Portfolio & Program Management That Rescued At-Risk Clinical Trials Case Studies: Portfolio & Program Management That Rescued At-Risk Clinical Trials Introduction to Portfolio and Program Management in Clinical Trials Clinical trials represent a critical component in the development of new therapies and medical interventions. However, the complexity and rigor involved in conducting these…

Read More “Case Studies: Portfolio & Program Management That Rescued At-Risk Clinical Trials” »

Case Studies: Portfolio & Program Management That Rescued At-Risk Clinical Trials Case Studies: Portfolio & Program Management That Rescued At-Risk Clinical Trials In the landscape of clinical trials, particularly in regions governed by strict regulatory authorities—namely the FDA in the U.S., EMA in the EU, and MHRA in the UK—the successful management of clinical projects…

Read More “Case Studies: Portfolio & Program Management That Rescued At-Risk Clinical Trials” »

Future Trends: AI, Automation and Analytics-Driven Portfolio & Program Management The landscape of clinical trials is rapidly evolving, driven by advancements in technology and data analytics. As clinical project management continues to adapt, it is imperative for professionals in the field to understand how artificial intelligence (AI), automation, and analytics are reshaping portfolio and program…

Read More “Future Trends: AI, Automation and Analytics-Driven Portfolio & Program Management” »

How to Adapt Portfolio & Program Management for Decentralized, Hybrid and Digital Trials How to Adapt Portfolio & Program Management for Decentralized, Hybrid and Digital Trials The clinical research landscape is undergoing rapid transformation, particularly with the increasing adoption of decentralized, hybrid, and digital trials. This adaptation is essential for clinical operations, regulatory affairs, and…

Read More “How to Adapt Portfolio & Program Management for Decentralized, Hybrid and Digital Trials” »

Operating Models for Scaling Portfolio & Program Management Across a Portfolio Operating Models for Scaling Portfolio & Program Management Across a Portfolio Successful management of clinical trials, especially for complex therapeutic areas like clinical trials for dental implants, demands strategic planning, comprehensive oversight, and efficient resource allocation. Given the ongoing push for more robust clinical…

Read More “Operating Models for Scaling Portfolio & Program Management Across a Portfolio” »